This message was posted by a user wishing to remain anonymous
What is common practice regarding human factors testing for a consumer-user medical device in terms of language requirements. For example if a product is available initially with instructions in English only and the company wishes to add other languages, should we be repeating human factors testing with all the translations or is some certification of the translation sufficient to say the original human factors testing in English was still applicable? Does FDA have any specific expectations?
Is it different globally - is all testing expected to be repeated for each language?